tiprankstipranks
Provention Bio (PRVB)
NASDAQ:PRVB

Provention Bio (PRVB) Income Statement

0 Followers

Provention Bio Income Statement

Last quarter (Q ), Provention Bio's total revenue was $10.77M, an increase of 1401.95% from the same quarter last year. In Q, Provention Bio's net income was $-33.32M. See Provention Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 12.10M$ 12.89M-$ 0.00$ 0.00$ 0.00
Cost of Revenue
------
Gross Profit
$ 10.77M$ 12.89M----
Operating Expense
$ 111.22M$ 141.06M-$ 99.69M$ 44.37M$ 26.81M
Operating Income
$ -99.13M$ -128.16M-$ -99.69M$ -44.37M$ -26.81M
Net Non Operating Interest Income Expense
$ 759.00K$ 1.20M-$ 583.00K$ 1.09M$ 669.00K
Other Income Expense
-----$ -520.00K
Pretax Income
$ -98.37M$ -126.96M-$ -99.10M$ -43.28M$ -26.66M
Tax Provision
$ -13.39M$ -13.39M-$ -523.00K$ 0.00$ -187.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -84.98M$ -113.56M-$ -98.58M$ -43.28M$ -26.75M
Basic EPS
$ -1.52$ -1.52$ -1.81$ -1.88$ -1.06$ -1.19
Diluted EPS
$ -1.15-$ -1.81$ -1.88$ -1.06$ -1.19
Basic Average Shares
$ 285.96M$ 74.72M$ 63.10M$ 52.46M$ 40.75M$ 22.44M
Diluted Average Shares
$ 211.24M-$ 63.10M$ 52.46M$ 40.75M$ 22.44M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 111.22M$ 141.06M-$ 99.69M$ 44.37M$ 26.81M
Net Income From Continuing And Discontinued Operation
$ -84.98M$ -113.56M-$ -98.58M$ -43.28M$ -26.48M
Normalized Income
$ -51.66M--$ -98.58M$ -43.28M$ -25.96M
Interest Expense
------
EBIT
$ -99.13M$ -128.16M-$ -99.69M$ -44.37M$ -26.81M
EBITDA
$ -58.64M--$ -99.65M$ -44.37M$ -26.81M
Currency in USD

Provention Bio Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis